An Antioxidant Response Phenotype Shared between Hereditary and Sporadic Type 2 Papillary Renal Cell Carcinoma

Ooi, Aikseng, Wong, Jing-Chii, Petillo, David, Roossien, Douglas, Perrier-Trudova, Victoria, Whitten, Douglas, Min, Bernice Wong Hui, Tan, Min-Han +9 more·2011·Cancer Cell

DOI 10.1016/j.ccr.2011.08.024

Cited by (405)

Items 201–300 of 405

Fumarate suppresses B-cell activation and function through direct inactivation of LYN
Jie Cheng, Ying Liu, Jinxin Yan, Lina Zhao, Ying‐Lin Zhou, Xu-Yang Shen, Yunan Chen, Yining Chen, Xianbin Meng, Xin‐Xiang Zhang et al. · 2022 · Nature Chemical Biology
Functional implications of fumarate-induced cysteine succination
Iva Guberović, Christian Frezza · 2024 · Trends in Biochemical Sciences
The KEAP1-NRF2 System and Esophageal Cancer
Wataru Hirose, Hiroyuki Oshikiri, Keiko Taguchi, Masayuki P. Yamamoto · 2022 · Cancers
A five-gene signature predicts overall survival of patients with papillary renal cell carcinoma
Ze Gao, Dong Zhang, Yi Duan, Lei Yan, Yidong Fan, Zhiqing Fang, Zhaoxu Liu · 2019 · PLoS ONE
Adenylosuccinate lyase is oncogenic in colorectal cancer by causing mitochondrial dysfunction and independent activation of NRF2 and mTOR-MYC-axis
Stephanie Taha‐Mehlitz, Gaia Bianco, Mairene Coto‐Llerena, Venkatesh Kancherla, Glenn R. Bantug, John Gallon, Caner Ercan, Federica Panebianco, Serenella Eppenberger‐Castori, Marco von Strauss et al. · 2021 · Theranostics
Mitochondrial Complex I activity signals antioxidant response through ERK5
Abrar Ul Haq Khan, Nerea Allende-Vega, Delphine Gitenay, Johan Garaude, Dang-Nghiem Vo, Sana Belkhala, Sabine Gerbal‐Chaloin, Claire Gondeau, Martine Daujat‐Chavanieu, Cécile Delettre et al. · 2018 · Scientific Reports
Multifaceted Roles of the KEAP1–NRF2 System in Cancer and Inflammatory Disease Milieu
Harit Panda, Huaichun Wen, Mikiko Suzuki, Masayuki P. Yamamoto · 2022 · Antioxidants
Metabolic Alterations in Cancer Cells and the Emerging Role of Oncometabolites as Drivers of Neoplastic Change
Zhengqiu Zhou, Elochukwu Ibekwe, Yevgen Chornenkyy · 2018 · Antioxidants
Fumaric acid esters promote neuronal survival upon ischemic stress through activation of the Nrf2 but not HIF-1 signaling pathway
Jiemeng Lin-Holderer, Lexiao Li, Daniel Gruneberg, Hugo H. Marti, Reiner Kunze · 2016 · Neuropharmacology
Targeting fuel pocket of cancer cell metabolism: A focus on glutaminolysis
Shagun Sharma, Navneet Agnihotri, Sandeep Kumar · 2022 · Biochemical Pharmacology
Comparative Analysis of Smoking as a Risk Factor among Renal Cell Carcinoma Histological Subtypes
Neel Patel, Kristopher M. Attwood, Michael I. Hanzly, Terrance T. Creighton, Diana Mehedint, Thomas Schwaab, ERIC C. KAUFFMAN · 2015 · The Journal of Urology
Insights into the Genetic Basis of the Renal Cell Carcinomas from The Cancer Genome Atlas
Scott Mattox Haake, Jamie D. Weyandt, W. Kimryn Rathmell · 2016 · Molecular Cancer Research
Serum aldo–keto reductase family 1 member B10 predicts advanced liver fibrosis and fatal complications of nonalcoholic steatohepatitis
Masataka Kanno, Kazunori Kawaguchi, Masao Honda, Rika Horii, Hajime Takatori, Tetsuro Shimakami, Kazuya Kitamura, Kuniaki Arai, Taro Yamashita, Yoshio Sakai et al. · 2019 · Journal of Gastroenterology
Impacts of NRF2 activation in non–small‐cell lung cancer cell lines on extracellular metabolites
Daisuke Saigusa, Ikuko N. Motoike, Sakae Saito, Michael Zorzi, Yuichi Aoki, Hiroshi Kitamura, Mikiko Suzuki, Fumiki Katsuoka, Hirofumi Ishii, Kengo Kinoshita et al. · 2019 · Cancer Science
Systematic expression analysis of the mitochondrial complex III subunits identifies UQCRC1 as biomarker in clear cell renal cell carcinoma
Jörg Ellinger, Arabella Gromes, Mirjam Poss, Maria Brüggemann, Doris H. Schmidt, Nadja Ellinger, Yuri Tolkach, Dimo Dietrich, Glen Kristiansen, Stefan C. Müller · 2016 · Oncotarget
Nrf2 and Keap1 abnormalities in esophageal squamous cell carcinoma and association with the effect of chemoradiotherapy
Jingze Zhang, Qinghua Jiao, Li Kong, Jing Yu, Aiju Fang, Minghuan Li, Jinming Yu · 2018 · Thoracic Cancer
Shadows of NRF2 in cancer: Resistance to chemotherapy
Bo-Hyun Choi, Mi‐Kyoung Kwak · 2016 · Current Opinion in Toxicology
Renal cell carcinoma: translational aspects of metabolism and therapeutic consequences
Oscar C. Y. Yang, Patrick Henry Maxwell, Patrick J. Pollard · 2013 · Kidney International
Aldo Keto Reductases AKR1B1 and AKR1B10 in Cancer: Molecular Mechanisms and Signaling Networks
Sreeparna Banerjee · 2021 · Advances in experimental medicine and biology
Metabolic Drivers in Hereditary Cancer Syndromes
Marco Sciacovelli, Christina Schmidt, Eamonn Richard Maher, Christian Frezza · 2019 · Annual Review of Cancer Biology
Fumarate hydratase inactivation in renal tumors: HIF1 alpha, NRF2, and "cryptic targets" of transcription factors
Aikseng Ooi, Kyle A. Furge · 2012 · 癌症：英文版
Berberine synergises with ferroptosis inducer sensitizing NSCLC to ferroptosis in p53-dependent SLC7A11-GPX4 pathway
Weilin Liao, Ren Zhang, Geer Chen, Xiaoyu Zhu, Weiyu Wu, Ziyu Chen, Chenyu Jiang, Zicong Lin, Lijuan Ma, Haijie Yu · 2024 · Biomedicine & Pharmacotherapy
Filtering through the role of NRF2 in kidney disease
Cody J. Schmidlin, Matthew B. Dodson, Donna D. Zhang · 2019 · Archives of Pharmacal Research
Erratum: Aldo-keto reductases are biomarkers of NRF2 activity and are co-ordinately overexpressed in non-small cell lung cancer
A Kenneth MacLeod, Lourdes Acosta-Jimenez, Philip John Coates, Michael J. McMahon, Frank A. Carey, Tadashi Honda, John D. Hayes, Colin J. Henderson, C. Roland Wolf · 2017 · British Journal of Cancer
Succinylation of a KEAP1 sensor lysine promotes NRF2 activation
Lara H. Ibrahim, Caroline R. Stanton, Kayla Nutsch, Thu T. A. Nguyen, Chloris Li-Ma, Yeonjin Ko, Gabriel C. Lander, R. Luke Wiseman, Michael J. Bollong · 2023 · Cell chemical biology
Electrophilic metabolites targeting the KEAP1/NRF2 partnership
Albena T. Dinkova‐Kostova, Henriikka Hakomäki, Anna–Liisa Levonen · 2024 · Current Opinion in Chemical Biology
Discoveries, therapies and opportunities
William Marston Linehan, Christopher J. Ricketts · 2014 · Nature Reviews Urology
Tracing Renal Cell Carcinomas back to the Nephron
David Lindgren, Jonas Sjölund, Håkan Axelson · 2018 · Trends in cancer
Molecular mechanisms and systemic targeting of NRF2 dysregulation in cancer
Jong-Su Kang, Le Ba Nam, Ok-Kyung Yoo, Young‐Sam Keum · 2020 · Biochemical Pharmacology
Reactivating PTEN to impair glioma stem cells by inhibiting cytosolic iron-sulfur assembly
Jianxing Yin, Xin Quan Ge, Fangshu Ding, Liuguijie He, Keying Song, Zhumei Shi, Zehe Ge, Junxia Zhang, Jing Ji, Xiefeng Wang et al. · 2024 · Science Translational Medicine
Recent advances in the biology of tumour hypoxia with relevance to diagnostic practice and tissue‐based research
Philip S. Macklin, Atsushi Yamamoto, Lisa Browning, Monika Hofer, Julie Adam, Christopher William Pugh · 2020 · The Journal of Pathology
AKR1B10 Is a New Sensitive and Specific Marker for Fumarate Hydratase-Deficient Renal Cell Carcinoma
Linmao Zheng, Xingming Zhang, Xiuyi Pan, Zhuo Huang, Mengxin Zhang, Jie Xian, Yuyan Wei, Ling Nie, Mengni Zhang, Jing Gong et al. · 2023 · Modern Pathology
The mechanistic insights of the antioxidant Keap1-Nrf2 pathway in oncogenesis: a deadly scenario
Anirban Goutam Mukherjee, Abilash Valsala Gopalakrishnan · 2023 · Medical Oncology
Role of the KEAP1-NRF2 Axis in Renal Cell Carcinoma
Sara Clerici, Alessandra Boletta · 2020 · Cancers
Changing perspective on oncometabolites: from metabolic signature of cancer to tumorigenic and immunosuppressive agents
Mauro Corrado, Luca Scorrano, Silvia Campello · 2016 · Oncotarget
Comprehensive genomic and phenotypic characterization of germline FH deletion in hereditary leiomyomatosis and renal cell carcinoma
Cathy D. Vocke, Christopher J. Ricketts, Maria J. Merino, Ramaprasad Srinivasan, Adam R. Metwalli, Lindsay A. Middelton, James C. Peterson, Youfeng Yang, William Marston Linehan · 2017 · Genes Chromosomes and Cancer
Role of succinate dehydrogenase deficiency and oncometabolites in gastrointestinal stromal tumors
Yue Zhao, Fei Feng, Qinghong Guo, Yuping Wang, Rui Zhao · 2020 · World Journal of Gastroenterology
Oxidative stress and NRF2 signaling in kidney injury
Cherry Ng, Iris Kim, Yanti Yanti, Mi‐Kyoung Kwak · 2024 · Toxicological Research
Cancer metabolomics in basic science perspective
Hyuk Nam Kwon, Sehyun Oh, Xing Jin, Yong An, Sunghyouk Park · 2015 · Archives of Pharmacal Research
Gene of the month: FH
Roman E. Zyla, Anjelica Hodgson · 2021 · Journal of Clinical Pathology
Colonic Lamina Propria Inflammatory Cells from Patients with IBD Induce the Nuclear Factor-E2 Related Factor-2 Thereby Leading to Greater Proteasome Activity and Apoptosis Protection in Human Colonocytes
Marie‐Luise Kruse, Martin Friedrich, Alexander Arlt, Christoph Röcken, Jan‐Hendrik Egberts, Susanne Sebens, H. Schäfer · 2016 · Inflammatory Bowel Diseases
mTORC1 Upregulation Leads to Accumulation of the Oncometabolite Fumarate in a Mouse Model of Renal Cell Carcinoma
Luca Drusian, Elisa Agnese Nigro, Valeria Mannella, Roberto Pagliarini, Monika Pema, Ana S.H. Costa, Fabio Benigni, Alessandro Larcher, Marco Chiaravalli, Edoardo Gaude et al. · 2018 · Cell Reports
Cullin 3 and Its Role in Tumorigenesis
Ruey‐Hwa Chen · 2020 · Advances in experimental medicine and biology
Genetic Alterations in Renal Cancers: Identification of The Mechanisms Underlying Cancer Initiation and Progression and of Therapeutic Targets
Ugo Testa, Elvira Pelosi, Germana Castelli · 2020 · Medicines
Integrated Phenotypic/Genotypic Analysis of Papillary Renal Cell Carcinoma Subtypes: Identification of Prognostic Markers, Cancer-related Pathways, and Implications for Therapy
Rola Saleeb, Pamela J. Plant, Eriny Tawedrous, Adriana Krizova, Fadi Brimo, Andrew John Evans, Samantha Jane Wala, John M.S. Bartlett, Qiang Ding, Dina Boles et al. · 2016 · European Urology Focus
Oxidative stress and mitochondrial adaptive shift during pituitary tumoral growth
María Eugenia Sabatino, Ezequiel Grondona, Liliana del Valle Sosa, Bethania Mongi‐Bragato, Lucia Carreño, Virginia Juárez, Rodrigo A. da Silva, Aline Pertile Remor, Lucila de Bortoli da Silva, Roberta de Paula Martins et al. · 2018 · Free Radical Biology and Medicine
Oncometabolites in cancer: from cancer cells to the tumor microenvironment
Luoyi Chen, Min Huang · 2024 · Holistic Integrative Oncology
Unlocking peak performance: The role of Nrf2 in enhancing exercise outcomes and training adaptation in humans
Miriam Martinez‐Canton, Víctor Galván-Álvarez, Marcos Martín-Rincón, José A. L. Calbet, Ángel Gallego-Selles · 2024 · Free Radical Biology and Medicine
Bach1 Inhibition Suppresses Osteoclastogenesis via Reduction of the Signaling via Reactive Oxygen Species by Reinforced Antioxidation
Satoshi Wada, Hiroyuki Kanzaki, Yuta Katsumata, Yuuki Yamaguchi, Tsuyoshi Narimiya, Otis C. Attucks, Yoshiki Nakamura, Hiroshi Tomonari · 2020 · Frontiers in Cell and Developmental Biology
Adipocyte Fatty Acid Binding Protein Potentiates Toxic Lipids-Induced Endoplasmic Reticulum Stress in Macrophages via Inhibition of Janus Kinase 2-dependent Autophagy
Ruby L.C. Hoo, Lingling Shu, Kenneth K.Y. Cheng, Xiaoping Wu, Boya Liao, Donghai Wu, Zhiguang Zhou, Aimin Xu · 2017 · Scientific Reports
Cancer and the Kidney: The Growth of Onco-nephrology
Mark Anthony Perazella, Jeffrey S. Berns, Mitchell Howard Rosner · 2013 · Advances in Chronic Kidney Disease
Health position paper and redox perspectives – Bench to bedside transition for pharmacological regulation of NRF2 in noncommunicable diseases
Cuadrado, Antonio, Cazalla, Eduardo, Bach, Anders, Bathish, Boushra, Naidu, Sharadha Dayalan, DeNicola, Gina M., Dinkova-Kostova, Albena T., Fernández-Ginés, Raquel, Grochot-Przeczek, Anna, Hayes, John D. et al. · 2025 · Redox Biology
NRF2 inhibitors: Recent progress, future design and therapeutic potential
Bingbing Lv, Shuaishuai Xing, Zhiqiang Wang, Ao Zhang, Qinjie Wang, Yaoyao Bian, Yuqiong Pei, Haopeng Sun, Yao Chen · 2024 · European Journal of Medicinal Chemistry
Genome-Wide CRISPR Screen Reveals Autophagy Disruption as the Convergence Mechanism That Regulates the NRF2 Transcription Factor
Michael John Kerins, Pengfei Liu, Wang Tian, William Mannheim, Donna D. Zhang, Aikseng Ooi · 2019 · Molecular and Cellular Biology
Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome in Spain: Clinical and Genetic Characterization
Ana Beatriz Sánchez‐Heras, Adela Castillejo, Juan de Dios García-Díaz, Mercedes Robledo, Àlex Teulé, Rosario Sánchez‐Martínez, Ángel Zúñiga, Enrique Lastra, Mercedes Durán, Gemma Llort et al. · 2020 · Cancers
Metabolic, autophagic, and mitophagic activities in cancer initiation and progression
Anita B. Hjelmeland, Jianhua Zhang · 2016 · Biomedical Journal
A novel uterine leiomyoma subtype exhibits NRF2 activation and mutations in genes associated with neddylation of the Cullin 3-RING E3 ligase
Miika M. Mehine, Terhi Ahvenainen, Sara Khamaiseh, Jouni Härkönen, Siiri Reinikka, Tuomas Heikkinen, Anna Äyräväinen, Päivi I. Pakarinen, Päivi Härkki, Annukka M. Pasanen et al. · 2022 · Oncogenesis
Using an Integrated -Omics Approach to Identify Key Cellular Processes That Are Disturbed in the Kidney After Brain Death
M.Z. Akhtar, Honglei Huang, Mohammed O. Kaisar, Maria Letizia Lo Faro, Rolando A. Rebolledo, Karl Morten, Lisa C. Heather, Anthony C. Dona, Henri G. D. Leuvenink, S Fuggle et al. · 2015 · American Journal of Transplantation
Nrf2 gene mutation and single nucleotide polymorphism rs6721961 of the Nrf2 promoter region in renal cell cancer
Yoshiyuki Yamaguchi, Takao Kamai, Satoru Higashi, Satoshi Murakami, Kyoko Arai, Hiromichi Shirataki, Ken‐Ichiro Yoshida · 2019 · BMC Cancer
Single-Cell Transcriptomes of Hereditary Kidney Cancers Underscore Genetically Defined Tumor Characteristics and Microenvironment
Ryosuke Jikuya, Koichi Murakami, Akira Nishiyama, Ikuma Kato, Mitsuko Furuya, Jun Nakabayashi, Jordan A. Ramilowski, Haruka Hamanoue, Kazuhiro Maejima, Masashi Fujita et al. · 2022 · iScience
Fumarate integrates metabolism and immunity in diseases
Jie Cheng, Yifeng Xiao, Peng Jiang · 2025 · Trends in Endocrinology and Metabolism
Pathologic Oxidation of PTPN12 Underlies ABL1 Phosphorylation in Hereditary Leiomyomatosis and Renal Cell Carcinoma
Yang Xu, Paul P. Taylor, Joshua Andrade, Beatrix M. Ueberheide, Brian M. Shuch, Peter M. Glazer, Ranjit S. Bindra, Michael F. Moran, William Marston Linehan, Benjamin G. Neel · 2018 · Cancer Research
Emerging role of nuclear factor erythroid 2-related factor 2 in the mechanism of action and resistance to anticancer therapies
P. Poornima, Ibrahim Hamza Kankia, Simon P. Langdon, Yusuf Deeni · 2019 · Cancer Drug Resistance
Three-gene risk model in papillary renal cell carcinoma: a robust likelihood-based survival analysis
Yutao Wang, Kexin Yan, Jiaxing Lin, Jianfeng Wang, Zhenhua Zheng, Xinxin Li, Zhixiong Hua, Yuepeng Bu, Jianxiu Shi, Siqing Sun et al. · 2020 · Aging
Functional genomics identifies novel genes essential for clear cell renal cell carcinoma tumor cell proliferation and migration
Christina A. Von Roemeling, Laura A. Marlow, Derek C. Radisky, Austin J Rohl, Hege E. Larsen, Johnny J. Wei, Heather Sasinowska, Heng Zhu, Richard R. Drake, Maciek Sasinowski et al. · 2014 · Oncotarget
Analysis of long non-coding RNA expression profiles in clear cell renal cell carcinoma
Fei Yang, Yan Wang, Jian Guo Wu, Shao Li Song, Gang Huang, Wei Xi, Li Tan, Jian Wang, Qing Cao · 2017 · Oncology Letters
Succination of Protein Thiols in Human Brain Aging
Mariona Jové, Irene Pradas, Natàlia Mota‐Martorell, Rosanna Cabré, Victòria Ayala, Isidró Ferrer, Reinald Pamplona · 2020 · Frontiers in Aging Neuroscience
Complex role of HIF in cancer: the known, the unknown, and the unexpected
Eric L. Huang, Patricia D.B. Tiburcio, Hyunsung Choi · 2014 · Hypoxia
Mitochondrial metabolic remodeling in response to genetic and environmental perturbations
Kate E.R. Hollinshead, Daniel A. Tennant · 2016 · WIREs Systems Biology and Medicine
Fumarate hydratase as a therapeutic target in renal cancer
Priyanka Kancherla, Michael Daneshvar, Rebecca Sager, Mehdi Mollapour, Gennady Bratslavsky · 2020 · Expert Opinion on Therapeutic Targets
Assessing Genomic Copy Number Alterations as Best Practice for Renal Cell Neoplasia: An Evidence-Based Review from the Cancer Genomics Consortium Workgroup
Yajuan J. Liu, Jane Houldsworth, Rajyasree Emmadi, Lisa M. Dyer, Daynna J. Wolff · 2020 · Cancer Genetics
Adipocyte protein modification by Krebs cycle intermediates and fumarate ester-derived succination
Allison M. Manuel, Norma Frizzell · 2013 · Amino Acids
Cyst(e)inase–Rapamycin Combination Induces Ferroptosis in Both In Vitro and In Vivo Models of Hereditary Leiomyomatosis and Renal Cell Cancer
Baris Kerimoglu, Candice Lamb, Ryan D. McPherson, Ergul Ergen, Everett M. Stone, Aikseng Ooi · 2022 · Molecular Cancer Therapeutics
Sustained NRF2 activation in hereditary leiomyomatosis and renal cell cancer (HLRCC) and in hereditary tyrosinemia type 1 (HT1)
Ivraj Singh Sandhu, Nicholas James Maksim, Eva A. Amouzougan, Bryce Wilson Gallion, Anthony L.J. Raviele, Aikseng Ooi · 2015 · Biochemical Society Transactions
A two-dimensional screen for AMPK substrates identifies tumor suppressor fumarate hydratase as a preferential AMPKα2 substrate
Anna Klaus, Cécile Polge, Sarah Zorman, Yolanda Auchli, René Brunisholz, Uwe Schlattner · 2012 · Journal of Proteomics
Deep learning with evolutionary and genomic profiles for identifying cancer subtypes
Chun‐Yu Lin, Peiying Ruan, Ruiming Li, Jinn‐Moon Yang, Simon Chong Wee See, Jiangning Song, Tatsuya Akutsu · 2019 · Journal of Bioinformatics and Computational Biology
A Case of Metastatic Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome-Associated Renal Cell Carcinoma Treated with a Sequence of Axitinib and Nivolumab Following Cytoreductive Nephrectomy
Ichiro Yonese, Masaya Ito, Kosuke null Takemura, Takao Kamai, Fumitaka Koga · 2020 · Journal of Kidney Cancer and VHL
Precision medicine for metastatic renal cell carcinoma
Guru Sonpavde, Toni K. Choueiri · 2013 · Urologic Oncology Seminars and Original Investigations
NCOA7 Regulates Growth and Metastasis of Clear Cell Renal Cell Carcinoma via MAPK/ERK Signaling Pathway
Jiayu Guo, Shuai Ke, Qi Chen, Jiangqiao Zhou, Jia Guo, Tao Qiu · 2023 · International Journal of Molecular Sciences
The molecular characterization and therapeutic strategies of papillary renal cell carcinoma
Qiwei Chen, Liang Cheng C, Quanlin Li · 2018 · Expert Review of Anticancer Therapy
Non-canonical roles for metabolic enzymes and intermediates in malignant progression and metastasis
Demond Williams, Barbara Fingleton · 2019 · Clinical & Experimental Metastasis
Recent advances in the systemic treatment of metastatic non‐clear cell renal cell carcinomas
Keiichi Ito · 2019 · International Journal of Urology
The Keap1-Nrf2 pathway: From mechanism to medical applications
Liam Baird, Masayuki P. Yamamoto · 2019 · Elsevier eBooks
A computational analysis of S-(2-succino)cysteine sites in proteins
Gianluca Miglio, Alessandro Sabatino, Eleonora Veglia, Marı́a Teresa Giraudo, Marco Beccuti, Francesca Cordero · 2015 · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
Radical nephrectomy and regional lymph node dissection for locally advanced type 2 papillary renal cell carcinoma in an at-risk individual from a family with hereditary leiomyomatosis and renal cell cancer: a case report
Takao Kamai, Hideyuki Abe, Kyoko Arai, Satoshi Murakami, Setsu Sakamoto, Yasushi Kaji, Ken‐Ichiro Yoshida · 2016 · BMC Cancer
Mitochondrial complex II regulates a distinct oxygen sensing mechanism in monocytes
Shraddha Sharma, Jianming Wang, Eduardo Cortes Gomez, R. Thomas Taggart, Bora E. Baysal · 2017 · Human Molecular Genetics
Synthetically Lethal Interactions of Heme Oxygenase-1 and Fumarate Hydratase Genes
Paulina Podkalicka, Olga Mucha, Szczepan Kruczek, Anna Biela, Kalina Andrysiak, Jacek Stępniewski, Maciej Mikulski, Michał Gałȩzowski, Kamil S. Sitarz, Krzysztof D. Brzózka et al. · 2020 · Biomolecules
Genetic, metabolic and immunological features of cancers with NRF2 addiction
Hiroshi Kitamura, Haruna Takeda, Hozumi Motohashi · 2022 · FEBS Letters
Physiological and molecular predictors of cycling sprint performance
Víctor Galván-Álvarez, Ángel Gallego-Selles, Miriam Martinez‐Canton, Ismael Pérez-Suárez, Eduardo García-Gonzalez, Marcos Martín-Rincón, José A. L. Calbet · 2024 · Scandinavian Journal of Medicine and Science in Sports
Pathogen-derived glyoxylate inhibits Tet2 DNA dioxygenase to facilitate bacterial persister formation
Zhou‐Li Cheng, ‪Shuyuan Zhang, Zhenning Wang, Aixia Song, Chao Gao, Junbin Song, Pu Wang, Lei Zhang, Yue Zhou, Wenyan Shan et al. · 2025 · Cell Metabolism
The complex role of NRF2 in cancer: A genomic view
Praslicka, Brandon John, Kerins, Michael John, Ooi, Aikseng · 2016 · Current Opinion in Toxicology
Cardio-Onco-Metabolism – Metabolic vulnerabilities in cancer and the heart
Anja Karlstaedt, Heinrich Taegtmeyer · 2022 · Journal of Molecular and Cellular Cardiology
Targeting NAD+ Metabolism Vulnerability in FH-Deficient Hereditary Leiomyomatosis and Renal Cell Carcinoma with the Novel NAMPT Inhibitor OT-82
Susana Sarai Najera, Christopher J. Ricketts, Laura S. Schmidt, Julia I. Medina, Keita Saito, Lilia V. Ileva, Jeffrey Brender, Amy E. James, Cody J. Peer, Brad A. Gouker et al. · 2024 · Molecular Cancer Therapeutics
SHMT2 regulates serine metabolism to promote the progression and immunosuppression of papillary renal cell carcinoma
Weiyu Kong, Zhongyuan Wang, Nuoran Chen, Yiwen Mei, Yang Li, Yulin Yue · 2022 · Frontiers in Oncology
Single nucleotide variants of succinate dehydrogenase A gene in renal cell carcinoma
Takao Kamai, Satoru Higashi, Satoshi Murakami, Kyoko Arai, Takashi Namatame, Toshiki Kijima, Hideyuki Abe, Tsengelmaa Jamiyan, Kazuyuki Ishida, Hiromichi Shirataki et al. · 2021 · Cancer Science
Urinary Metabolomics Validates Metabolic Differentiation Between Renal Cell Carcinoma Stages and Reveals a Unique Metabolic Profile for Oncocytomas
Oluyemi S. Falegan, Shanna A. Arnold Egloff, Andries Zijlstra, M. Eric Hyndman, Hans J. Vogel · 2019 · Metabolites
A challenging frontier – the genomics and therapeutics of nonclear cell renal cell carcinoma
Hiren V. Patel, Arnav Srivastava, Ramaprasad Srinivasan, Eric A. Singer · 2021 · Current Opinion in Oncology
Mitochondrial metabolism in TCA cycle mutant cancer cells
Lucas B. Sullivan, Navdeep S. Chandel · 2013 · Cell Cycle
Contemporary Renal Tumor Categorization With Biomarker and Translational Updates: A Practical Review
Alexander S. Taylor, Daniel Eidelberg Spratt, Saravana Mohan Dhanasekaran, Rohit Mehra · 2019 · Archives of Pathology & Laboratory Medicine
Mitochondrial Tumor Suppressors—The Energetic Enemies of Tumor Progression
Pavel Jakoubě, Valentina Cutano, Juan M. González-Morena, Zuzana Keckesova · 2021 · Cancer Research